SOX15 Transcriptionally Decreases the Level of MMP2 and Inhibits Vasculogenic Mimicry to Slow Down the Progression of Ovarian Cancer
- Xiaodan Zhao 1, Xinjia Wang 1, Chao Wang 1, Huiyu Tian 1, Yang Zhou 1, Lihong Gong 2
- Xiaodan Zhao 1, Xinjia Wang 1, Chao Wang 1
- 1Department of Physical Diagnosis, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
- 2Department of Gynecology, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
- 0Department of Physical Diagnosis, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sex-determining region Y-box 15 (SOX15) suppresses ovarian cancer progression by inhibiting vascular mimicry. SOX15 directly represses matrix metalloproteinase-2 (MMP2) expression, offering a new therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Vascular mimicry (VM) promotes tumor growth and invasion in ovarian cancer.
- Sex-determining region Y-box 15 (SOX15) is known to suppress tumor growth, but its role in ovarian cancer is unclear.
Purpose Of The Study
- To investigate the function of SOX15 in ovarian cancer cell proliferation, invasion, and vascular mimicry.
- To elucidate the underlying molecular mechanisms of SOX15 action in ovarian cancer.
Main Methods
- Utilized SKOV-3 and ES2 ovarian cancer cell lines and xenograft mouse models.
- Assessed cell proliferation, migration, and invasion.
- Measured VE-cadherin, VEGFA, Ki67, and MMP2 expression.
- Performed dual-luciferase reporter and ChIP-PCR assays to determine SOX15's mechanism of action.
Main Results
- SOX15 overexpression inhibited proliferation, migration, and invasion in ovarian cancer cells.
- SOX15 reduced VM formation by downregulating VE-cadherin and VEGFA.
- SOX15 knockdown increased tumor growth and VM formation in vivo.
- SOX15 directly repressed MMP2 promoter activity and expression.
Conclusions
- SOX15 acts as a tumor suppressor in ovarian cancer by transcriptionally repressing MMP2.
- Inhibiting VM formation through the SOX15/MMP2 axis presents a potential therapeutic strategy for ovarian cancer.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:23
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
03:03
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

